(Q37129351)

18 August 2017

1 reference

title

Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease (English)

1 reference

18 August 2017

James G Ryall

2

0 references

Gordon S. Lynch

object named as

Gordon S Lynch

series ordinal

1

0 references

language of work or name

1 reference

1 April 2008

1 reference

18 August 2017

Physiological Reviews

1 reference

18 August 2017

88

1 reference

18 August 2017

2

1 reference

18 August 2017

729-767

1 reference

Perioperative use of alpha2-adrenoceptor agonists and the cardiac patient

18 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Adverse effects of beta-agonists: are they clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of clenbuterol on normal and denervated muscle growth and contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta Adrenoceptor Agonists, Clenbuterol, and Isoproterenol Retard Denervation Atrophy in Rat Gastrocnemius Muscle: Use of 3-Methylhistidine as a Marker of Myofibrillar Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular characterization of an anchor protein (AKAPCE) that binds the RI subunit (RCE) of type I protein kinase A from Caenorhabditis elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta 3 and atypical beta-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Catabolic mediators as targets for cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Enhanced mtDNA repair capacity protects pulmonary artery endothelial cells from oxidant-mediated death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A-kinase anchoring proteins take shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Modulation of lipoprotein lipase activity in the rat by the beta 2-adrenergic agonist clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Further evidence of the inhibitory role of perifornical hypothalamic beta-adrenergic receptors in the feeding behaviour of hungry rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of clenbuterol on sexual behavior in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Left ventricular assist device and drug therapy for the reversal of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

G proteins in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Early metabolic and endocrine effects of perorally administered beta-adrenoceptor agonists in calves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular tinkering of G protein-coupled receptors: an evolutionary success

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Epac: a new cAMP target and new avenues in cAMP research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Rap1 signalling: adhering to new models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Symptoms and correlates of anabolic-androgenic steroid dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Myotoxic effects of clenbuterol in the rat heart and soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The metabolism of cyclic-3'-5'-adenosine monophosphate (cAMP) in diseased muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of the beta(2)-agonist clenbuterol on the locomotor activity of rat submitted to a 14-day period of hypodynamia-hypokinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

21 January 2018

The many faces of CREB

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Calcium microdomains and gene expression in neurons and skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol reduces soleus muscle fatigue during disuse in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Muscle wasting associated with endotoxemia in the rat: modification by the beta 2-adrenoceptor agonist clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Drugs and sport. Research findings and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short-term agonist exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

From muscle disuse to myopathy in COPD: potential contribution of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

CNG and HCN channels: two peas, one pod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ion-channel regulation by G proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The abuse of doping agents in competing body builders in Flanders (1988-1993).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Protein kinase A anchoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-arrestins and cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Search for new cyclic AMP-binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Apoptosis in skeletal muscle and its relevance to atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular basis for interactions of G protein betagamma subunits with effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Pilot trial of albuterol in Duchenne and Becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The influence on nerve regeneration by the beta2-receptor agonist clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regeneration of peripheral nerves after clenbuterol treatment in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cloning of the cDNA for the human beta 1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Nobel Lecture. G proteins and regulation of adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Skeletal muscle hypertrophy and atrophy signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Duality of G protein-coupled mechanisms for beta-adrenergic activation of NKCC activity in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Changes in contractile activation characteristics of rat fast and slow skeletal muscle fibres during regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ractopamine induces differential gene expression in porcine skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Arrestins: ubiquitous regulators of cellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of terbutaline on force and intracellular calcium in slow-twitch skeletal muscle fibres of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Heterotrimeric G proteins: new tricks for an old dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation and role of adenylyl cyclase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Functional activity of antibodies at the bovine beta2-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta 2-adrenoceptor densities do not correlate with growth, carcass quality, or meat quality in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of corticosterone on beta-adrenoceptor density in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Differential phosphorylation and dephosphorylation of beta2-adrenoceptor sites Ser262 and Ser355,356.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The effect of the beta2-adrenoceptor agonist prodrug BRL-47672 on cardiovascular function, skeletal muscle myosin heavy chain, and MyoD expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Intracellular signaling during skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Four beta-adrenoceptor subtypes in the mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Stimulation of cyclic AMP-dependent protein kinase in rat atria by (-)-CGP 12177 through an atypical beta-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Myocardial infarction in a 17-year-old body builder using clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of arrestin-3 phosphorylation by casein kinase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-adrenergic agonists and hypertrophy of skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Essential role for the second extracellular loop in C5a receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Formation of inactive cAMP-saturated holoenzyme of cAMP-dependent protein kinase under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

G-protein betagamma-subunits contribute to the coupling specificity of the beta2-adrenergic receptor to G(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Localization of the Ca(2+)-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Control of calcium release and the effect of ryanodine in skinned muscle fibres of the toad

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

{alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Presynaptic regulation of catecholamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Positive inotropic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A review of the toxicology of salbutamol (albuterol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cyclic adenosine monophosphate-phosphodiesterase inhibitors reduce skeletal muscle protein catabolism in septic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Emerging drugs for sarcopenia: age-related muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Tackling Australia's future health problems: developing strategies to combat sarcopenia--age-related muscle wasting and weakness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Therapeutic approaches for muscle wasting disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of chronic clenbuterol administration and exercise training on immune function in horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The action of the beta-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The influence of the sympathetic nervous system on individual vessels of the microcirculation of skeletal muscle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red, and intermediate skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Skeletal muscle apoptosis, sarcopenia and frailty at old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Transcriptional regulation by the phosphorylation-dependent factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cloning and characterization of A-kinase anchor protein 100 (AKAP100). A protein that targets A-kinase to the sarcoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

AKAP signaling complexes: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Role of beta ARK in long-term agonist-promoted desensitisation of the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Signaling chromatin to make muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Receptor activation: what does the rhodopsin structure tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

AKAP mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Adipose tissue, longissimus muscle and anterior pituitary growth and function in clenbuterol-fed heifers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Distinct sites on G protein beta gamma subunits regulate different effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Illegal use of beta-adrenergic agonists in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of receptor trafficking by GRKs and arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Isoproterenol-induced hypertrophy may result in distinct left ventricular changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ras is involved in nerve-activity-dependent regulation of muscle genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular determinants of skeletal muscle mass: getting the "AKT" together

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Adrenergic control of protein metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The transcriptional coactivators p300 and CBP are histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Alternative splicing generates isoforms of human neuron-derived orphan receptor-1 (NOR-1) mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Calcineurin and heat-shock proteins modulation in clenbuterol-induced hypertrophied rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Overview of PDEs and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Restoration of myocardial beta-adrenergic receptor signaling after left ventricular assist device support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

What does chronic electrical stimulation teach us about muscle plasticity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Role of β1- and β2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Physiological roles of G protein-coupled receptor kinases and arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Rap1 regulates E-cadherin-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Heterodimerization of g protein-coupled receptors: specificity and functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Crystal structure of the human beta2 adrenergic G-protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of clenbuterol on growth, carcase and skeletal muscle characteristics in broiler chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Microdomains of intracellular Ca2+: molecular determinants and functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Targeting of Protein Kinase A by Muscle A Kinase-anchoring Protein (mAKAP) Regulates Phosphorylation and Function of the Skeletal Muscle Ryanodine Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The effects of in utero exposure of lambs to a beta-adrenergic agonist on prenatal and postnatal muscle growth, carcass cutability, and meat tenderness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Phospholamban mediates the beta-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The response of transgenic mice to beta-adrenergic agonist administration is different from that of normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Technologies for the control of fat and lean deposition in livestock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effect of salbutamol on innervated and denervated rat soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

SOCS-3 induces myoblast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Changes in skeletal muscle gene expression following clenbuterol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Biotechnology of beta-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Localized effects of cAMP mediated by distinct routes of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Outlook for therapy in the muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of the p300 HAT domain via a novel activation loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Calpains and muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Metabolic and hormonal interactions between muscle and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The many forks in FOXO's road

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Strength training and albuterol in facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Functional characteristics of dystrophic skeletal muscle: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Chronopharmacological study of acetylsalicylic acid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Ubiquitin and ubiquitin-like proteins as multifunctional signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Evolution of the mammalian G protein alpha subunit multigene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The positive inotropic effect of epinephrine on skeletal muscle: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Regulated ubiquitination of proteins in GPCR-initiated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Recent advances in cardiac beta(2)-adrenergic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Lysine acetylation and the bromodomain: a new partnership for signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Clenbuterol retards loss of motor function in motor neuron degeneration mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

The beta2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00028.2007

10.1152/PHYSREV.00028.2007

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18391178